REPLIMUNE GROUP INC's ticker is REPL and the CUSIP is 76029N106. A total of 112 filers reported holding REPLIMUNE GROUP INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $745,141 | -24.4% | 43,550 | +2.6% | 0.01% | -33.3% |
Q2 2023 | $986,084 | +49.6% | 42,467 | +13.8% | 0.01% | +50.0% |
Q1 2023 | $659,195 | -28.1% | 37,327 | +10.7% | 0.01% | -25.0% |
Q4 2022 | $917,048 | +97.2% | 33,715 | +25.1% | 0.01% | +100.0% |
Q3 2022 | $465,000 | -8.6% | 26,952 | -7.4% | 0.00% | -20.0% |
Q2 2022 | $509,000 | -38.2% | 29,114 | -40.0% | 0.01% | -44.4% |
Q1 2022 | $824,000 | -44.0% | 48,522 | -10.6% | 0.01% | -47.1% |
Q4 2021 | $1,471,000 | -13.4% | 54,269 | -5.3% | 0.02% | +6.2% |
Q3 2021 | $1,699,000 | -27.9% | 57,322 | -6.6% | 0.02% | -23.8% |
Q2 2021 | $2,358,000 | -7.1% | 61,387 | -26.2% | 0.02% | -16.0% |
Q1 2021 | $2,537,000 | -18.2% | 83,148 | +2.3% | 0.02% | -28.6% |
Q4 2020 | $3,101,000 | +162.1% | 81,295 | +58.2% | 0.04% | +105.9% |
Q3 2020 | $1,183,000 | -4.8% | 51,379 | +2.8% | 0.02% | 0.0% |
Q2 2020 | $1,242,000 | +92.0% | 49,986 | -23.0% | 0.02% | +70.0% |
Q1 2020 | $647,000 | -37.8% | 64,887 | -10.4% | 0.01% | +25.0% |
Q4 2019 | $1,040,000 | – | 72,446 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Omega Fund Management, LLC | 5,344,971 | $122,395,000 | 33.11% |
Corriente Advisors, LLC | 512,500 | $11,798,000 | 5.98% |
Bain Capital Life Sciences Investors, LLC | 2,122,415 | $48,858,000 | 4.55% |
BVF INC/IL | 1,691,834 | $38,946,000 | 2.12% |
Redmile Group, LLC | 3,330,999 | $76,680,000 | 1.41% |
EMERALD ADVISERS, LLC | 891,761 | $20,528,000 | 0.84% |
EMERALD MUTUAL FUND ADVISERS TRUST | 823,989 | $18,968,000 | 0.84% |
Penn Mutual Asset Management, LLC | 15,877 | $365,000 | 0.52% |
EAM Global Investors LLC | 54,274 | $1,249,000 | 0.46% |
Artal Group S.A. | 700,000 | $16,114,000 | 0.39% |